Published May 25, 2023
| Version v2
Journal article
Open
Antibody Characterization Report for Leucine-rich repeat kinase 2 (LRRK2)
Authors/Creators
- 1. Montreal Neurological Institute
- 2. Advanced BioImaging Facility (ABIF), McGill University
Description
Head-to-head comparison of available commercial antibodies against Leucine-rich repeat kinase 2 (LRRK2) by immunoblot (Western blot), immunoprecipitation and immunofluorescence.
The following study was funded in part by Genome Québec's Genomics Integration Program, awarded to the research laboratory of Peter S. McPherson. This work was supported by the Michael J. Fox Foundation for Parkinson's research.
Files
Leucine-rich repeat kinase 2_LRRK2_YCharOS report_v2.pdf
Files
(7.7 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:05b946e7652ebe56a581d5fd9d044e36
|
7.7 MB | Preview Download |